ARTICLES IN THIS WEB SITE IS FOR YOUR REFERENCE ONLY. IF YOU HAVE ANY QUESTION, YOU SHOULD CONSULT WITH YOUR
DOCTOR IMMEDIATELY. ALL RIGHT RESERVED 2008. DO NOT COPY NOR TRANSFER ARTICLES TO OTHER WEBSITES NOR OTHER
FORMS OF PUBLICATIONS.
FDA News
The list below is incomplete. For more news, you should check with
FDA website.
DRUG
INDUSTRY

Foundamental
Science
Colloidal Stabilization

Drug Product
Development
Patent Application
Product Development
Product Ingredients
Colorant
Scale up a batch 1
Drug Delivery Industry
Drug Delivery - Smart
Bomb
Lotion, Cream, Preps
Enteric Coating-Eudragit
Enteric Coating-Nutrateric
SR Coating-Aquacoat

Drug Industry
Drug Competitions
Drug in Development
Cholesterol-lowering
Drug-Terminologies
Packaging Materials

Market
Drug Dev- 2004
Drug Dev - 2005Q1
Drug Dev- 2005Q2
Drug Dev-2005Summer
Drug Dev-2005Q3
Orphan Drug
Protein Drug
Niche Market

Novo Norkdisk R&D

Equipment
Blenders

CONTRACT
MANUFACT.
Nutrition Supplements
Popular Search
Abilify
Accutane
Actonel
Actoplus
Actos
AcuTect
Adderall
Agenerase
Aggrastat
Alamast
Alimta
Alinia
Aloxi
Alrex
Ambien CR
Amerge
Amidarone
Amitiza
Amphadase
Ampligen
Antagon
Apidra
Apokyn
Aptivus
Arava
Arqatroban
Aripiprazole
Avanafil
Arixtra
Aromasin
Arranon
Asmanex
Atacand
Avandia
Avastin
Duodote
Erbitux
Gardasil
GDNF
Gemzar
Ghrelin
GRN163
Herceptin
Increlex
IPLEX
Keppra
Levemir
Levothyroxine
Liraqlutide
Lithium
Carbonate
Lucentis
Lyrica
Omnitrope
Prezista
PSN010
PX12
Remicade
Revlimid
Rozerem
Sorafenib
Sutent
Tamsulosin
TNF Blockers
Torcetrapib
Tykerb
Tysabri
Vectibix
Xeloda
Xenical
Zoledronic acid
June 17, 2008 FDA Warns Individuals and Firms to Stop
Selling Fake Cancer 'Cures'

July 8, 2008 FDA Requests Boxed Warnings on
Fluoroquinolone Antimicrobial Drugs

July 9, 2008 FDA Revises Process for Responding to Drug
Applications

July 18, 2008 FDA Rule and Companion Guidance Make
Early Stage Clinical Drug Development Safe and Efficient

July 24, 2008 Federal Authorities Seize Xiadafil VIP Tablets
After Company Refuses to Recall Product

July 29, 2008 FDA Approves First Generic Divalproex Sodium
to Treat Seizures, Migraine Headaches and Bipolar Disorder

July 30, 2008 Federal Agents Seize more than $24 Million in
Unapproved New Drugs

July 31, 2008 FDA Clears Test that Helps Identify Type of
Cancer in Tumor Sample

August 15, 2008 FDA Approves First Drug for Treatment of
Chorea in Huntington’s Disease - Xenazine